GS

Goldman Sachs BDC IncNYSE GSBD Stock Report

Last reporting period 30 Sep, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

1.681

Small

Exchange

XNYS - New York Stock Exchange, Inc

GSBD Stock Analysis

GS

Avoid

Based on Eyestock quantitative analysis, GSBD`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

39/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-35.8 %

Overvalued

Market cap $B

1.681

Dividend yield

12.48 %

Shares outstanding

102.96 B

Goldman Sachs BDC, Inc. invests in middle market companies located in the US. The company is headquartered in New York City, New York. The company went IPO on 2015-03-18. The firm is a primarily engaged in specialty finance that is focused on lending to middle-market companies. The Company’s investment objective is to generate current income and capital appreciation primarily through direct originations of secured debt, including first lien debt, unitranche loans, including last-out portions of such loans, and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments. The company also invests in investments, such as in large United States companies, foreign companies, stressed or distressed debt, structured products or private equity. The company invests in various sectors, such as software, healthcare providers and services, professional services, consumer services and supplies, healthcare equipment and supplies, chemicals, textiles, and apparel and luxury goods. Goldman Sachs Asset Management, L.P. is the investment advisor of the Company.

View Section: Eyestock Rating